首页> 外国专利> SYNERGISM BETWEEN LOW MOLECULAR HEPARIN AND INHIBITORS AGAINSTATION OF PLATELETS THAT PROVIDES COMBINED THERAPY FOR PREVENTION AND TREATMENT OF DIFFERENT THROMBOEMBOLIC DISORDERS

SYNERGISM BETWEEN LOW MOLECULAR HEPARIN AND INHIBITORS AGAINSTATION OF PLATELETS THAT PROVIDES COMBINED THERAPY FOR PREVENTION AND TREATMENT OF DIFFERENT THROMBOEMBOLIC DISORDERS

机译：低分子肝素与抗血小板抑制剂之间的协同作用，为预防和治疗不同的血栓性代谢障碍提供了综合疗法。

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a combination therapy comprising administering a low molecular weight heparin, such as tinzaparin, and a platelet antagonist GPIIb / IIIa, such as roxifiban, for treating, preventing, and reducing the risk of thromboembolic disorders. The international search report was published 2002.01.24.

机译：本发明涉及一种联合疗法，其包括给予低分子量肝素如替扎肝素和血小板拮抗剂GPIIb / IIIa如roxifiban，以治疗，预防和减少血栓栓塞性疾病的风险。国际检索报告发表于2002.01.24。

著录项

公开/公告号EA200100965A1

专利类型
公开/公告日2002-08-29

原文格式PDF
申请/专利权人 ДЮПОН ФАРМАСЬЮТИКАЛЗ КОМПАНИ;
展开▼

申请/专利号EA20010000965
发明设计人 ВОНГ ПАНКРАС К.;МУСА ШЕЙКЕР А.;
展开▼

申请日2000-03-10
分类号C07D261/10;A61K31/222;A61K31/4015;A61K31/402;A61K31/42;A61K31/422;A61K31/445;A61K31/4465;A61K31/60;A61K31/616;A61K31/715;A61K31/727;A61K38;A61K38/46;A61K39/395;A61K45;A61K45/06;A61P7/02;A61P9;A61P9/08;A61P9/10;C07K16/28;
国家 EA
入库时间 2022-08-22 00:45:32

相似文献

专利
外文文献
中文文献